These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20854177)

  • 1. MicroRNAs as therapeutic targets for lung cancer.
    Cho WC
    Expert Opin Ther Targets; 2010 Oct; 14(10):1005-8. PubMed ID: 20854177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy.
    Cho WC
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1273-81. PubMed ID: 20026422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-183 regulates Ezrin expression in lung cancer cells.
    Wang G; Mao W; Zheng S
    FEBS Lett; 2008 Oct; 582(25-26):3663-8. PubMed ID: 18840437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micromanagers of malignancy: role of microRNAs in regulating metastasis.
    Ma L; Weinberg RA
    Trends Genet; 2008 Sep; 24(9):448-56. PubMed ID: 18674843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA regulation of cell viability and drug sensitivity in lung cancer.
    Du L; Pertsemlidis A
    Expert Opin Biol Ther; 2012 Sep; 12(9):1221-39. PubMed ID: 22731874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in ovarian cancer biology and therapy resistance.
    van Jaarsveld MT; Helleman J; Berns EM; Wiemer EA
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1282-90. PubMed ID: 20083225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA dysregulation in cancer: opportunities for the development of microRNA-based drugs.
    Nana-Sinkam SP; Croce CM
    IDrugs; 2010 Dec; 13(12):843-6. PubMed ID: 21154140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of non-small-cell lung cancer and pharmacogenomics: where we are and where we are going.
    Rosell R; Cuello M; Cecere F; Santarpia M; Reguart N; Felip E; Taron M
    Curr Opin Oncol; 2006 Mar; 18(2):135-43. PubMed ID: 16462182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype.
    Santarpia L; Nicoloso M; Calin GA
    Endocr Relat Cancer; 2010 Mar; 17(1):F51-75. PubMed ID: 19843580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting.
    Wu DW; Cheng YW; Wang J; Chen CY; Lee H
    Cancer Res; 2010 Dec; 70(24):10392-401. PubMed ID: 21159652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis.
    Shi M; Liu D; Duan H; Shen B; Guo N
    Cancer Metastasis Rev; 2010 Dec; 29(4):785-99. PubMed ID: 20938719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of microRNAs to radio- and chemoresistance of brain tumors and their therapeutic potential.
    Chistiakov DA; Chekhonin VP
    Eur J Pharmacol; 2012 Jun; 684(1-3):8-18. PubMed ID: 22484336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of microRNAs in breast cancer.
    Adams BD; Guttilla IK; White BA
    Semin Reprod Med; 2008 Nov; 26(6):522-36. PubMed ID: 18951334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging role of microRNAs in resistance to lung cancer treatments.
    MacDonagh L; Gray SG; Finn SP; Cuffe S; O'Byrne KJ; Barr MP
    Cancer Treat Rev; 2015 Feb; 41(2):160-9. PubMed ID: 25592062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.
    Li T; Li D; Sha J; Sun P; Huang Y
    Biochem Biophys Res Commun; 2009 Jun; 383(3):280-5. PubMed ID: 19302977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.
    Crawford M; Brawner E; Batte K; Yu L; Hunter MG; Otterson GA; Nuovo G; Marsh CB; Nana-Sinkam SP
    Biochem Biophys Res Commun; 2008 Sep; 373(4):607-12. PubMed ID: 18602365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED.
    Incoronato M; Garofalo M; Urso L; Romano G; Quintavalle C; Zanca C; Iaboni M; Nuovo G; Croce CM; Condorelli G
    Cancer Res; 2010 May; 70(9):3638-46. PubMed ID: 20388802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptomirs: small molecules have gained the license to kill.
    Vecchione A; Croce CM
    Endocr Relat Cancer; 2010 Mar; 17(1):F37-50. PubMed ID: 19815577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets.
    Motadi LR; Misso NL; Dlamini Z; Bhoola KD
    Int Immunopharmacol; 2007 Dec; 7(14):1934-47. PubMed ID: 18039530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.